Aortic stenosis and mitral regurgitation: implications for transcatheter valve treatment.

MedStar author(s):
Citation: Eurointervention. 9 Suppl:S69-71, 2013 Sep 10.PMID: 24025961Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Aortic Valve | *Aortic Valve Stenosis/th [Therapy] | *Cardiac Catheterization | *Heart Valve Prosthesis Implantation/mt [Methods] | *Mitral Valve | *Mitral Valve Insufficiency/th [Therapy] | Aortic Valve Stenosis/ep [Epidemiology] | Comorbidity | Disease Management | Humans | Mitral Valve Insufficiency/ep [Epidemiology] | Risk Factors | Severity of Illness Index | Treatment OutcomeISSN:
  • 1774-024X
Name of journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of CardiologyAbstract: Moderate or severe mitral regurgitation (MR) is a common finding in patients with severe aortic stenosis (AS). The combination may be a relative indication for double valve surgery, particularly when MR is severe, degenerative, associated with left atrial dilation, chronic atrial fibrillation, or mitral annular calcium. However, in patients for whom open surgery is not desirable, TAVI may provide a reasonable therapeutic strategy with an expectation in selected patients that MR may improve, be better tolerated, or be amenable to staged transcatheter mitral interventions. In this paper, we briefly review the surgical experience with concomitant AS and MR and discuss the potential implications of transcatheter-based heart valve techniques in this patient group.All authors: Barbanti M, Dvir D, Tan J, Webb JGDigital Object Identifier: Date added to catalog: 2014-04-04
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article Available 24025961

Moderate or severe mitral regurgitation (MR) is a common finding in patients with severe aortic stenosis (AS). The combination may be a relative indication for double valve surgery, particularly when MR is severe, degenerative, associated with left atrial dilation, chronic atrial fibrillation, or mitral annular calcium. However, in patients for whom open surgery is not desirable, TAVI may provide a reasonable therapeutic strategy with an expectation in selected patients that MR may improve, be better tolerated, or be amenable to staged transcatheter mitral interventions. In this paper, we briefly review the surgical experience with concomitant AS and MR and discuss the potential implications of transcatheter-based heart valve techniques in this patient group.

English

Powered by Koha